Schwab Network 对 $GILD 的判断变化

频道资料 →频道引用的来源:BFA and JP Morgan、Baird、Bank of America、Barclays、Berenberg、Bernstein、Bernstein, with a Jefferies target cut noted、Bilal Little、Bird (analyst firm)、CEO、CEO Joe Dominguez、Caner、Citi、Citigroup、Citizens、Daiwa、Dan Deming and Michael Monahan、Dan Ies; Morgan Stanley、Dan Ives、Dan Ives and unnamed analysts、Deutsche Bank、Erit Research、Evercore ISI、Evercore ISI; Dan Ives、Goldman Sachs、JP Morgan Chase、JPMorgan、JPMorgan Chase、James Demerard of Wall Street Research、Jefferies、Jefferies, UBS and Citigroup、Jensen Huang; Dan Ives、KeyBank、Loop Capital、Mattie Natsson、Michael Saylor、Milius (analyst)、Morgan Stanley、Northrop、Oppenheimer、Oppenheimer, Freedom Broker、Oracle、PFA analysts、Quantum CEO、RBC、Reddit CEO、Rothschild Redburn、SK Hynix、Seth、Tim Bigham、Tim and KG、Truist、UBS、Wall Street Journal、Wedbush、Wells Fargo、analysts、the street共 1 条

Schwab Network 自 2026-10-15 起在 1 个视频里谈过 $GILD,最近一次(2026-10-15)为看涨。

2026-10-15看涨
《The Big 3: MRK, GILD, XOM》
AI 摘要 · GILD 突破长达九个月、位于 153 阻力下方的底部形态,出现向上跳空缺口,动能强劲但未超买,仍有进一步上行空间;生物科技板块走强及实体瘤乐观情绪提供支撑。财报隐含的高波动率可能抵消看涨缺口;财报后若回落至 155 则具吸引力。

我们有一家公司叫Gilead Sciences。他们今天创下新纪录。他们上涨了3.3%。他们经历了一轮非常强劲的上涨。他们在实体瘤领域有一个合作项目,似乎引发了大量乐观情绪。

We have a company called "Gilead Sciences". They set a new record today. They have increased by 3.3 percent. They have seen a really strong rise. They have a partnership in the field of solid tumors that seems to be generating a lot of optimism.

类似。这个板块有点不同,我认为它是医疗保健和生物技术之间的混合体。所以,再次强调,如果你看看生物技术过去几个月的相对强度,尤其是最近几天,你会发现这是一个展现出能够抵御科技板块部分抛压能力的板块。

这就是我今天选择关注这个名字的原因,也因为当你观察现在的价格走势时,我们看到今天出现了显著的上涨,而这只股票似乎有望维持这轮上涨趋势。

Similarly. This sector is a little different, and I think it's a mix between healthcare and biotechnology . So, again, if you look at the relative strength of biotechnology over the past several months, and particularly in the last few days, you will find that it is a sector that is showing an ability to withstand some of the selling pressure in the technology sector.

This is why I chose to focus on this name today, and also because when you look at the price action now, we see a significant upward move today, and the stock appears poised to maintain this upward trend.